
Anastrozole
Form: Oral Tablet
Strength: 1 mg
Reference Brands: Arimidex®(US & EU)
Category: Oncology Cancer Care
Anastrozole 1 mg Tablets are a key treatment in the management of hormone receptor-positive breast cancer. Available in both brand name (Arimidex®) and generic formulations, Anastrozole is used in adjuvant and metastatic settings for postmenopausal women. It works as a non-steroidal aromatase inhibitor, reducing estrogen production to slow or stop the growth of estrogen-dependent breast cancers. Anastrozole is widely available in both the U.S. and EU and is a core component of oncology B2B offerings in breast cancer therapies. With 1 mg tablets as the standard strength, it is a critical medication in global oncology markets.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View Details Get EnquiryDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View Details Get EnquirySunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View Details Get EnquiryIfosfamide
Strength: 1 g/vial,2 g/vial, 3 g/vial
Form: Injection
Reference Brands: Ifex® (US), Holoxan® (EU)
View Details Get Enquiry